Table 2.
Subtype of RCC | Number of Patients (N:172) | Positive Cases for PDL1 | Mean Positivity of PD-L1 in Tumor Cells |
---|---|---|---|
HLRCC | 53 | 31 (58.4%) | 34.5% |
Clear Cell RCC (VHL) | 34 | 0 (0%) | 0 % |
Type 1 PRCC | 31 | 10 (32.2%) | 41.1% |
Chromophobe RCC | 20 | 7 (35.0%) | 25.7% |
Hybrid Tumor | 9 | 3 (33.3%) | 30% |
RCC-TFE3 | 8 | 3 (37.5%) | 56.7% |
Oncocytoma | 7 | 0 (0%) | 0 % |
Undifferentiated | 5 | 3 (60%) | 38.3% |
RCC with SDHB mutation | 3 | 0 (0%) | 0% |
TFEB-RCC | 2 | 2 (100%) | 55% |
Total | 172 | 59 |